Applying a low-flow CO2 removal device in severe acute hypercapnic respiratory failure

Area of Science:

• Critical Care Medicine
• Respiratory Physiology
• Medical Device Technology

Background:

• Severe acute hypercapnic respiratory failure presents a significant clinical challenge, often requiring advanced respiratory support.
• Standard mechanical ventilation may be insufficient in managing extreme hypercapnia and associated acidosis.
• Extracorporeal CO2 removal (ECCO2R) offers a potential adjunctive therapy to enhance gas exchange.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel, portable extracorporeal CO2-removal device.
• To assess the device's ability to augment gas transfer in patients with severe acute hypercapnic respiratory failure.
• To determine the impact of the device on blood gas parameters and acid-base balance.

Main Methods:

• A prospective evaluation of a portable ECCO2R device in five adult subjects with severe acute hypercapnic respiratory failure.
• Percutaneous insertion of a dual-lumen catheter connected to the ECCO2R device.
• Monitoring of blood gas parameters (PaCO2, pH) and device performance (blood flow rate, duration of support).

Main Results:

• The device successfully reduced mean PaCO2 from 95.8 ± 21.9 mmHg to 63.9 ± 19.6 mmHg within 4 hours.
• Mean pH improved from 7.11 ± 0.1 to 7.26 ± 0.1 in the initial 4 hours of support.
• No systemic bleeding or device-related complications were observed during the study period.

Conclusions:

• Low-flow extracorporeal CO2 removal, as an adjuvant to standard therapy, effectively removes CO2 and limits acidosis progression.
• The novel portable device demonstrates safety and efficacy in managing severe acute hypercapnic respiratory failure.
• This ECCO2R approach offers a viable option for patients refractory to conventional mechanical ventilation.